GRP logo
Medication Compliance and Persistence: Terminology and Definitions

Medication Compliance and Persistence: Terminology and Definitions

The citation for this report is:
Cramer JA, Roy A, Burrell A, et al. Medication Compliance and Persistence: Terminology and Definitions. Value Health 2008;11: 44-7.

Developed by the Medication Adherence & Persistence Special Interest Group

Chair:
Joyce A. Cramer, BS, Yale University School of Medicine, New Haven, CT, USA

Leadership Group:
Anuja Roy, MBA, MSc, West Virginia University, Morgantown, WV, USA
Anita Burrell, MBA, Sanofi-Aventis, Paris, France
Carol J. Fairchild, PhD, Alcon Laboratories, Ft. Worth, TX, USA
Mahesh J. Fuldeore, PhD, RPh, MBA, TAP Pharmaceuticals, Lake Forest, IL, USA
Daniel A. Ollendorf, MPH, PharMetrics, Watertown, MA, USA
Peter K. Wong, PhD, RPh, MS, MBA, Mercy Health Partners, Southwest Ohio, Cincinnati, OH, USA


SPOR Good Practices For Outcomes Research Index | ISPOR Medication Compliance and Persistence Special Interest Group (MCP)